XML 33 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Revenues $ 151,941 $ 77,447 $ 104,883
Costs and expenses:      
Cost of product sales 3,351 2,651 0
Research and development 207,026 214,577 193,201
Selling, general and administrative 58,949 63,014 42,742
Total costs and expenses 273,359 280,242 235,943
Loss from operations (121,418) (202,795) (131,060)
Other income 1,660 680 1,321
Net loss (119,758) (202,115) (129,739)
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 56 (54) (23)
Other comprehensive income (loss):      
Comprehensive loss $ (119,702) $ (202,169) $ (129,762)
Basic weighted average number of common shares outstanding (in shares) 61,433,124 59,944,717 52,442,389
Diluted weighted average number of common shares outstanding (in shares) 61,433,124 59,944,717 52,442,389
Cost of manufacturing services $ 4,033 $ 0 $ 0
Earnings Per Share, Basic $ (1.95) $ (3.37) $ (2.47)
Earnings Per Share, Diluted $ (1.95) $ (3.37) $ (2.47)
Revenue from collaborative agreements      
Revenues:      
Revenues $ 119,303 $ 63,294 $ 97,764
Revenue from government agreements      
Revenues:      
Revenues 1,923 1,804 7,119
Product      
Revenues:      
Revenues 16,727 12,349 0
Contract Manufacturing      
Revenues:      
Revenues $ 13,988 $ 0 $ 0